Helomics Starts AI-based Tumor Sequencing Aimed at Predicting OC Treatment Responses
News
Helomics, a subsidiary of Predictive Oncology, has begun sequencing tumor samples as part of its collaboration with UPMC Magee Women’s Hospital. The partners aim to use artificial intelligence (AI) to ... Read more